(19)
(11) EP 3 727 344 A1

(12)

(43) Date of publication:
28.10.2020 Bulletin 2020/44

(21) Application number: 18826316.4

(22) Date of filing: 19.12.2018
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/40(2006.01)
 A61K 9/24(2006.01)
A61K 31/4422(2006.01)
(86) International application number:
PCT/EP2018/085746
(87) International publication number:
WO 2019/121857 (27.06.2019 Gazette 2019/26)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 20.12.2017 EP 17208852

(71) Applicant: Midas Pharma GmbH
55218 Ingelheim (DE)

(72) Inventors:
  • KAHM, Andreas
    55218 Ingelheim (DE)
  • JÜNEMANN, Daniel
    65346 Eltville (DE)

(74) Representative: Drescher, Christian 
Stauferring 36
55218 Ingelheim am Rhein
55218 Ingelheim am Rhein (DE)

   


(54) FIXED DOSED PHARMACEUTICAL COMPOSITIONS COMPRISING AMLODIPINE, RAMIPRIL AND ATORVASTATIN